New NO-donors with antithrombotic and vasodilating activities, XI: 2-Nitrosiminobenzimidazoles.
Thirteen 1,3-disubstituted title compounds were synthesized and tested for their antiplatelet activity (Born test, collagen). Three derivatives inhibited the platelet aggregation halfmaximally in concentrations < 20 mumol/L.